Abstract |
The articles by De Knegt et al. and Singh et al. in a recent issue of this Journal address one of the current debates regarding the potential role of thioridazine in the treatment of tuberculosis. This commentary presents a summary of the available evidence, and, emphasizing the need for further research, asks the question: "How far can we go in repurposing thioridazine?"
|
Authors | Noton K Dutta, Petros C Karakousis |
Journal | Tuberculosis (Edinburgh, Scotland)
(Tuberculosis (Edinb))
Vol. 94
Issue 6
Pg. 708-11
(Dec 2014)
ISSN: 1873-281X [Electronic] Scotland |
PMID | 25293998
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Comment)
|
Copyright | Copyright © 2014 Elsevier Ltd. All rights reserved. |
Chemical References |
- Antitubercular Agents
- Pyrazinamide
- Thioridazine
- Isoniazid
- Rifampin
|
Topics |
- Animals
- Antitubercular Agents
(pharmacology)
- Female
- Isoniazid
(pharmacology)
- Mycobacterium tuberculosis
(drug effects)
- Pyrazinamide
(pharmacology)
- Rifampin
(pharmacology)
- Thioridazine
(pharmacology)
- Tuberculosis
(drug therapy)
|